ArticleMolecular and clinical oncology2025

Efficacy and safety of anlotinib combined with vinorelbine as second‑line treatment for elderly patients with advanced squamous cell lung carcinoma: A retrospective cohort.

Yonghong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.